Immunosuppressive Pharmacotherapy Flashcards

1
Q

2 phases of immunosuppressive pharmacotherapy are…

A

1) Induction therapy
2) Maintenance therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Risk of acute rejection is highest…

A

In the first 1-3 months after transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Induction therapy improves efficacy of immunosuppression by…

A

Reducing acute rejection, and allowing for reduction in other maintenance medications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Induction therapy consists of…

A

IL-2 receptor antagonist or lymphocyte depleting antibody
+
Triple therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

A common IL-2 receptor antagonist used is…

A

Basiliximab (Simulect)

This is usually standard practice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

MOA of IL-2 receptor antagonists is…

A

Binds to IL-2 receptor on activated lymphocytes, preventing IL-2 binding to receptor

Block T-cell pathway, no proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Safety/tolerability of IL-2 receptor antagonists is…

A

Usually well tolerated, no DI’s
Possibility of acute hypersensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Most common lymphocyte depleting antibody is…

A

Anti-thymocyte globulin (ATG, thymoglobulin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

MOA of ATG is…

A

Antibodies will bind to antigens found on surface of T-cells, and depletes T-cells from circulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Potency of ATG compared to IL-2 receptor antagonists is…

A

Greater - can be used for induction or cell-mediated rejection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Safety/tolerability of ATG is…

A

Bone marrow suppression - platelets/leukocytes may be affected as well
Anaphylaxis, hepatic, infusion related reactions

Think more potent than basiliximab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Dosing for ATG is unique because it is…

A

Weight-based
Lifetime doses are also counted to balance risk vs. immunosuppression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Maintenance immunosuppression regimens usually consist of…

Triple therapy

A

Corticosteroid
Antiproliferative (Mycophenolate, azathioprine)
Calcineurin inhibitors (Cyclosporine, tacrolimus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MOA of corticosteroids for immunosuppression is…

A

Up-regulates expression of anti-inflammatory proteins, represses expression of proinflammatory proteins

Inhibits antigen presentation, cytokine production, + proliferation of lymphocytes (broad spectrum immunosuppressant)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Dosing of corticosteroids (prednisone) is…

A

Initially IV, then switched to oral prednisone + tapered to lowest effective dose

Usually 5-10 mg/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Short-term AE’s with prednisone include…

A

Insomnia
Personality changes
GI issues
Glucose alterations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Long-term AE’s with prednisone include…

A

Musculoskeletal changes
Osteoporosis
Cataracts

Are relevant to discuss since usage will be indefinite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

To help prevent complications of osteoporosis with long-term prednisone usage, we should…

A

Do routine bone density measurements
Pharmacotherapy - calcium, vitamin D, bisphosphonates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

To help prevent complications of hyperglycemia with long-term prednisone usage, we should…

A

Hope it resolves with tapering doses
Modify diet, usage of oral hypoglycemis/insulin if needed

Also consider than tacrolimus may increase BG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Mycophenolate is used more commonly than azathioprine because…

A

Mycophenolate does not affect other rapidly dividing cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

An important drug interaction to remember with azathioprine is…

A

Allopurinol - risk of myelosuppression, need to dose adjust

22
Q

MOA of azathioprine and mycophenolic acid derivatives is…

A

Purine analog - affects purine synthesis + metabolism, suppresses T and B cells
Mycophenolate is more specific than azathioprine

23
Q

AE’s of mycophenolate include…

A

GI - diarrhea, nausea, indigestion
Neutropenia
Anemia

24
Q

When taking mycophenolate, this is required for both males and females…

A

Birth control - teratogenic

25
Q

Relevant drug interactions with mycophenolate include…

A

Divalent cations (iron, calcium)
Cholestyramine
Food - decreases rate, but not extent of absorption

Food/drugs can help minimize GI since adherence is super important

26
Q

GI AE’s with mycophenolate can be managed via…

A

Rule out infectious cause
Administer with food or acid suppressive medication
Divide total daily dose into 3/4 doses, or decrease if possible
Try alternate formulation
Diarrhea = loperamide if non-infectious
Maybe change to azathioprine

27
Q

Neutropenia can be managed via…

A

Reducing dose if possible
Look for other drug causes + eliminate if possible
Filgrastim/GCSF if needed (proliferates WBC’s)

28
Q

MOA of calcineurin inhibitors (CNI’s)

Tacro, cyclo

A

Forms complex that binds with calcineurin - inhibition of calcineurin impairs expression of several cytokine genes that promotes T-cell activation

29
Q

CNI’s require ____ for safety.

A

Therapeutic drug monitoring - narrow therapeutic index

30
Q

Cyclosporine drug levels can be taken at…

A

Trough (C0) or 2 hour post dose (C2)

31
Q

Timing of cyclosporine drug levels is important to obtain accurate levels. C0 and C2 timing is…

A

C2 - no more than 15 minutes from 2 hour mark
C0 - 11.5-12.5 hours after last dose

32
Q

Cyclosporine drug levels are dependent on…

A

Various patient factors - time since transplant, match, AE’s, history, type of organ transplant

Individualized levels

33
Q

An important factor to note about tacrolimus formulations is that…

A

They are NOT bioequivalent !
Advagraf = once daily dosing
Prograf = Q12hours

Envarsus is newer and is also once daily

34
Q

Tacrolimus drug levels can be taken at…

A

Trough level only (C0).
No C2

35
Q

Timing of tacrolimus drug levels is important to obtain accurate levels. C0 timing is…

A

Preferably no more than 30 minutes from the C0 hour mark

36
Q

Tacrolimus drug levels are dependent on…

A

Various patient factors - time since transplant, match, AE’s, history, type of organ transplant

Individualized levels

37
Q

AE’s with CNI’s include…

A

Nephrotoxicity - acute + chronic
Neurotoxicity (dose-related), headache, tremor, dizziness, fatigue
HTN
Electrolyte imbalances
GI issues
Hepatotoxicity

38
Q

Cyclosporine unique AE’s include…

A

Higher rates of increased lipid levels, BP, and uric acid
Hirsutism, acne, gingival hyperplasia unique

39
Q

Tacrolimus unique AE’s include…

A

Higher rates of headache, GI issues (diarrhea), BG levels
Alopecia unique

40
Q

HTN, Increased BG, and increased lipid levels from CNI are treated…

A

Similar to general population
With statin, use lowest dose possible and monitor lab values (higher rates of muscle aches/weakness)

41
Q

Notable DI’s with CNI’s include…

A

CYP3A4 drugs - most common = erythromycin, clarithromycin, diltiazem, verapamil, antifungals, rifampin, grapefruit juice
Avoid if possible - dose adjustment/drug level management if cannot be avoided

Take DI’s seriously in this population !

42
Q

PD interactions with CNI’s include…

A

NSAID’s, nephrotoxic medications
Think similar to CKD population

43
Q

Sirolimus is an mTor inhibitor, where the MOA is to…

A

Engage TOR to reduce cytokine-dependent cellular proliferation of G1-S phase of the cell division cycle. Does not block calcineurin

Considered “less potent” than a CNI

44
Q

DI’s with sirolimus are…

A

Similar to CNi’s

45
Q

mTor inhibitors would be used when…

A

CNI’s cannot be used - declining renal function
Malignancy (?anti-tumour properties)
Potentially as add-on therapy for those needing increased immunsuppression despite triple therapy

46
Q

Notable AE’s with sirolimus include…

A

Proteinuria
Increased BP, lipids
Anemia, thrombocytopenia

Arthralgia
Rash - possibly dose related
Mouth sores
Edema, non-responsive to diuretic
Delayed wound healing

If experiencing, may need to reduce dose or just stop drug

47
Q

If a patient experiences acute cellular rejection, we can give…

A

High dose steroids
Antibody therapy - ATG

48
Q

If a patient experiences humoral rejection, we could give…

A

Plasmapheresis
High dose steroids
ATG, IV immune globulin

Could also give other antibodies directed against B lymphocytes

49
Q

If a patient experiences chronic rejection, we could try…

A

Increasing maintenance immunosuppression

50
Q

All transplant patients are required to have bloodwork for life - frequency depends on…

A

Time post-transplant
Clinical status of the patient
Type of organ transplant

51
Q

Bloodwork assists in monitoring…

A

For rejection
For toxicity from immunosuppressive medications

52
Q

Standard bloodwork consists of…

A

Drug levels (CNI, mTor)
Renal function
Hematology/CBC
Electrolytes

May also include cholesterol panel, etc.